Risks of paxlovid in a heart transplant recipient

The burden of morbidity and mortality from SARS-CoV-2 infection is especially significant in heart transplant patients who are at higher risk for poor outcomes owing to immunosuppression, blunted response to vaccination, and multiple comorbid conditions. Over the last 3 years the therapeutic landsca...

Descripción completa

Detalles Bibliográficos
Autores principales: Stawiarski, Kristin, Avery, Robin, Strout, Sara, Umapathi, Priya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Heart and Lung Transplantation. 2023
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452411/
https://www.ncbi.nlm.nih.gov/pubmed/36344373
http://dx.doi.org/10.1016/j.healun.2022.08.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452411/
https://www.ncbi.nlm.nih.gov/pubmed/36344373
http://dx.doi.org/10.1016/j.healun.2022.08.029

Ejemplares similares